Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MET642
MET642
Another NASH player retreats from battered field after toxicology study flags potential delay
Endpoints
Mon, 10/25/21 - 10:55 am
Metacrine
NASH
MET642
clinical trials
IBD